ASCE+ SRLV-E Derma Signal Kit in Pakistan: Evidence, Quality and Clinic Buying Guide

ASCE+ SRLV-E Derma Signal Kit in Pakistan: Evidence, Quality and Clinic Buying Guide clinical product guide visual

ASCE+ SRLV-E is an ExoCoBio two-part professional topical kit whose published label identifies a lyophilized powder and diluent for wrinkle care and skin rejuvenation.

Its U.S. DailyMed entry is a label record, not FDA approval, and explicitly categorizes the product as unapproved. Clinics should distinguish ExoCoBio's product positioning and ingredient disclosures from independently proven outcomes for a specific treatment protocol.

Catalogue visual: ASCE+ SRLV-E (Derma Signal Kit) from the NEES Medical product catalogue. Packaging appearance alone does not establish authenticity; verify the supplied batch, expiry, seals and traceability documents.

What it is

The ASCE+ Derma Signal Kit SRLV is described in DailyMed as a topical kit labeled by ExoCoBio. The record lists leucine and isoleucine as active ingredients and includes Rosa damascena callus extracellular vesicles, peptides, amino acids and other components in the powder, with sodium hyaluronate among the diluent ingredients.

The published route is topical, the pack is identified as single-use, and the label states 2–8°C storage. This article does not recommend an administration procedure and does not treat the presence of extracellular vesicles as proof of a licensed biologic therapy.

Market position and alternatives

SRLV-E is positioned in professional post-procedure and skin-quality care. Its value proposition differs from a regulated dermal filler, prescription medicine or energy-based device, so comparisons should focus on intended role, evidence and regulatory status rather than a single promise such as rejuvenation.

CategoryWhat it is intended to doKey distinction
ASCE+ SRLV-EManufacturer-positioned professional topical skin-care kit.DailyMed records the topical label but states that it is unapproved and not found by FDA to be safe and effective.
Hyaluronic acid skin products or fillersRange from topical moisturization to regulated injectable volume correction.Material, route and risk profile differ; an injectable filler is a medical device and not equivalent to SRLV-E.
Platelet-rich plasmaAutologous procedure used by some clinics for skin-quality indications.Requires blood processing and a clinical procedure; evidence and protocols vary.
Standard post-procedure skincareBarrier support and symptom-focused cosmetic care.Often simpler and lower cost, with product choice driven by the procedure and skin tolerance.

Potential advantages

  • ExoCoBio and ASCE+ provide an identifiable manufacturer and professional brand behind the SRLV line.
  • The public label discloses a two-part presentation, ingredients, topical route, warnings and refrigerated storage.
  • The kit format supports single-use stock control when handled exactly as the supplied label requires.
  • Published exosome literature gives clinics a broader evidence context, while still requiring caution about product-specific extrapolation.

Limitations and buying considerations

  • DailyMed states that the U.S. SRLV listing is an unapproved drug and that its labeling has not been approved by FDA.
  • Evidence across aesthetic exosome products is heterogeneous, and one product's formulation, source and protocol cannot be assumed equivalent to another's.
  • The label route is topical; injection or other unlabelled use should not be inferred from marketing terms such as professional or regenerative.
  • Long-term product-specific effectiveness and safety are not established by the manufacturer label alone.
  • NEES Medical's product-specific authorization should be described only if current manufacturer evidence can be produced; the cited public sources do not confirm it.

Quality and authenticity checklist

  • Match the product name, ExoCoBio labeler, powder-and-diluent presentation and printed route to official sources.
  • Confirm that seals are intact and batch and expiry information is consistent on the carton and both components.
  • Request and retain 2–8°C cold-chain documentation together with the dated invoice.
  • Check importer or supplier credentials and applicable Pakistan regulatory documentation before clinic use.
  • Escalate a questionable code, label, missing component or packaging difference to an official ExoCoBio contact.

Price and availability in Pakistan

ASCE+ SRLV-E Derma Signal Kit pricing in Pakistan is supplied by quotation. Confirm the exact kit, available quantity, batch, expiry, refrigerated delivery conditions and included documentation before comparing offers.

The lowest advertised price is not necessarily the lowest procurement risk when the seller cannot document product identity and temperature history.

Clinical safety: ASCE+ SRLV-E should be selected and handled by qualified professionals according to the exact topical label, local requirements and an individual clinical assessment. Direct all patient-specific, prescribing, procedural and administration questions to an appropriately qualified, licensed healthcare professional.

Sources and further reading

View the ASCE+ SRLV-E (Derma Signal Kit) catalogue page or request current pricing and availability.

Frequently Asked Questions

What is the ASCE+ SRLV-E price in Pakistan?

A current quotation is required. Ask for stock, exact kit presentation, batch, expiry, cold-chain delivery and documentation in the written quote.

Is a DailyMed listing proof that SRLV-E is FDA-approved?

No. The DailyMed record explicitly says the product has not been found by FDA to be safe and effective and that its labeling has not been approved by FDA.

How can a clinic check ASCE+ SRLV-E authenticity?

Verify ExoCoBio identity, intact powder and diluent components, matching batch and expiry data, invoice, refrigerated handling and any official authentication feature on the supplied pack.

How should ASCE+ SRLV-E be stored and how long does it last?

The published label states 2–8°C storage. Use the expiry on the intact kit and obtain evidence that the required temperature was maintained through distribution.

When should visible skin results appear?

A universal product-specific timeline is not established by high-quality independent trials. Timing depends on baseline skin, the wider treatment plan and how outcomes are measured by the responsible practitioner.

Is ASCE+ SRLV-E an injectable exosome treatment?

The cited DailyMed route is topical. This guide does not support injection or another route that conflicts with the exact label and local regulation.

Previous Post

No earlier post

Next Post

No newer post

NEES Medical Editorial author portrait
Written by
NEES Medical Editorial

NEES Medical editorial contributor covering skincare, professional catalog structure, and clinic buying guidance for Pakistan.

Editorial and medical review standards